CANY
MLAB icon

Caxton Associates (New York)’s Mesa Laboratories MLAB Stock Holding History

Caxton Associates (New York)’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,930
Closed -$202K – 540
2023
Q4 		$202K Buy
+1,930
New +$188K 0.01% 425
2019
Q2 		– Sell
-884
Closed -$204K – 481
2019
Q1 		$204K Buy
+884
New +$200K 0.03% 335

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Caxton Associates (New York)'s MLAB Position: Q1 2024 in Review

Caxton Associates (New York) sold out of Mesa Laboratories (MLAB) in Q1 2024, closing a stake of 1,930 shares — an estimated $202K sold.

Caxton Associates (New York) first reported a position in MLAB in Q1 2019 and held it in 2 quarters. The position peaked at $204K in Q1 2019. 155 funds tracked by Wall St. Rank hold MLAB as of Q1 2024.

  • Caxton Associates (New York) reported no remaining Mesa Laboratories position as of Q1 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 1,930 Mesa Laboratories shares in Q1 2024, an estimated $202K.
  • Caxton Associates (New York) first reported a position in Mesa Laboratories in Q1 2019 and held it in 2 quarters.
  • Caxton Associates (New York)'s Mesa Laboratories position peaked at $204K in Q1 2019.
  • 155 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.